SCHEMBL7370906

SCHEMBL7370906

CN1C(=O)/C(=C\c2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 2/20 0.57
EGFR P00533 1/20 0.57
IGF1R P08069 1/20 0.57
MAPT P10636 3/20 0.54
APP P05067 1/20 0.54
SNCA P37840 1/20 0.54
CTRC Q99895 1/20 0.53
EEF2K O00418 1/20 0.52
SRC P12931 1/20 0.52
SIRT1 Q96EB6 1/20 0.51
TRPA1 O75762 1/20 0.50
NPC1 O15118 1/20 0.50
MTOR P42345 1/20 0.50
RAB9A P51151 1/20 0.50
POLB P06746 1/20 0.50
STAT3 P40763 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7370909 1.00 ERBB2 (0.57) ERBB2EGFRIGF1RMAPTAPP
SCHEMBL8546141 0.84 EGFR (0.54) ERBB2EGFRIGF1RMAPTAPP
SCHEMBL8539935 0.84 MAPT (0.57) ERBB2EGFRIGF1RMAPTAPP
SCHEMBL8544253 0.84 ERBB2 (0.54) ERBB2EGFRIGF1RCTRCEEF2K
SCHEMBL7320051 0.83 EGFR (0.53) ERBB2EGFRIGF1RMAPTAPP
SCHEMBL7320047 0.83 EGFR (0.53) ERBB2EGFRIGF1RMAPTAPP
SCHEMBL7312445 0.82 PLK4 (0.52) ERBB2EGFRIGF1RCTRCEEF2K
SCHEMBL7312451 0.82 PLK4 (0.52) ERBB2EGFRIGF1RCTRCEEF2K
SCHEMBL8539170 0.80 CTRC (0.54) ERBB2EGFRIGF1RMAPTAPP
SCHEMBL8543090 0.80 EGFR (0.50) ERBB2EGFRIGF1RMAPTAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420428-B1 TREATING HEPATITIS C AND HEPATIC FIBROSIS USING 2,6-DI-TERT-BUTYLPHENOL DERIVATIVES; EFFECTIVE IN SUBJECTS WITH INTERFERON INSUSCEPTIBILITY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-07-16 US disclosed
US-6369097-B1 Treatment and prevention of hepatic disorders THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-04-09 US disclosed
US-6348493-B1 TREATMENT OF HEPATITIS C BY ADMINISTERING 2,6-DI-TER-BUTYLPHENOL THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-02-19 US disclosed
US-6218437-B1 ADMINISTERING A THERAPEUTIC AMOUNT OF DI-TERT-BUTYLPHENOL DERIVATIVE TO SUBJECT UNDER CONDITIONS SUCH THAT SAID SYMPTOMS ARE DIMINISHED THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-04-17 US disclosed
WO-2001021166-A1 TREATMENT AND PREVENTION OF HEPATIC DISORDERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-03-29 WO disclosed
US-5124347-A Inhibits 5-lipoxygenase and cyclooxygenase; for treatment of allergies, arthritis, pain WARNER-LAMBERT CO. (US) 1992-06-23 US disclosed